News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bit.bio Introduces ioAstrocytes, Enhancing Brain Modeling Capabilities for Researchers
Thursday, June 20, 2024Bitbio a pioneering company in synthetic biology focused on coding human cells for novel therapies has unveiled ioAstrocytes as its latest addition to the ioCells portfolio This new offering aims to revolutionize
Singleron Biotechnologies Collaborates with Human Cell Atlas to Broaden Global Access to Single-Cell Analysis
Wednesday, June 19, 2024Singleron Biotechnologies has partnered with the Human Cell Atlas to accelerate global adoption of singlecell sequencing Through this collaboration Singleron will provide its singlecell analysis platform
Ascidian Therapeutics Collaborates with Roche on RNA Exon Editing Treatments for Neurological Disorders
Wednesday, June 19, 2024Ascidian Therapeutics a company that specializes in RNAbased therapies has entered into a research collaboration and licensing agreement with Roche This collaboration aims to develop RNA exon
Neurona Therapeutics Obtains FDA RMAT Designation for NRTX-1001 in Treating Focal Epilepsy
Wednesday, June 19, 2024Neurona Therapeutics a company in the clinical stage focusing on regenerative cell therapies for disorders of the nervous system has received RMAT designation from the FDA
EUROAPI and Priothera Enter CDMO Agreement for an Oncology Project
Wednesday, June 19, 2024EUROAPI has secured a fiveyear agreement with Priothera a biotechnology company that specializes in treatments for blood cancers and enhancements in CART cell therapies Priothera operates out of Dublin Ireland with an additional branch in SaintLouis...
RevOpsis and Kemwell Biopharma Establish Partnership to Accelerate the Development of Innovative Multispecific Biologics
Tuesday, June 18, 2024RevOpsis Therapeutics a pioneering biopharmaceutical company focused on multispecific ophthalmic therapies and Kemwell Biopharma a toptier contract development and manufacturing organization
Charles River and Captain T Cell Collaborate on Plasmid DNA and Viral Vector Manufacturing for Gene-Modified Cell Therapy
Tuesday, June 18, 2024Charles River Laboratories International Inc has entered into an agreement with Captain T Cell a spinoff from the prestigious Max Delbrck Center in Berlin Germany to collaborate on a plasmid DNA
Acquisition of Argatroban Business in Europe
Monday, June 17, 2024Ethypharm has entered into an agreement with Mitsubishi Tanabe Pharma Corporation MTPC to acquire the selective antithrombin agent Argatroban monohydrate marketed under various brands including Argatra Arganova Novastan Exembol for distribution in Eu...
XEOMIN® (IncobotulinumtoxinA) Receives Approval for New Therapeutic Use in Switzerland
Saturday, June 15, 2024Merz Therapeutics a division of the Merz Group specializing in neurotoxins has recently obtained approval from Swissmedic the Swiss Agency for Therapeutic Products for XEOMIN
Biosplice and Novo Nordisk Collaborate on Diabetes Solutions
Friday, June 14, 2024Biosplice Therapeutics Inc a leader in biotechnology specializes in creating innovative treatments through the use of smallmolecule inhibition targeting DYRKCLK kinases Recently Biosplice has formed a strategic alliance with Novo Nordisk to develop n...
